SPOTLIGHT -
Joshua Fitch is an editor for Contemporary Pediatrics.
Voluntary Recall of Atovaquone Oral Suspension Due to Potential Bacillus cereus Contamination
The pneumonia drug Atovaquone oral suspension, USP 750mg/5mL, has been voluntarily recalled due to potential Bacillus cereus contamination.
Read More
